NASDAQ:VTVT

vTv Therapeutics News Headlines

$0.45

-0.02 (-4.48%)

(As of 05/20/2022 04:00 PM ET)

Add

Compare

Today's Range: $0.42
▼
$0.54
50-Day Range: $0.39
▼
$0.84
52-Week Range: $0.38
▼
$2.88

Volume: 202,600 shs
Average Volume: 256,180 shs
Market Capitalization: $40.85 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: -1.43

Get vTv Therapeutics News Delivered to You Automatically

Media Mentions By Week

vTv Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VTVT
News Sentiment
▼
0.00

0.30
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VTVT Articles
This Week
▼
4

1
▲
VTVT Articles
Average Week

vTv Therapeutics (NASDAQ:VTVT) News Headlines Today

Source

Source	Headline
	Comparing vTv Therapeutics (NASDAQ:VTVT) and 89bio (NASDAQ:ETNB) americanbankingnews.com - May 21 at 2:02 AM
	vTv Therapeutics (NASDAQ:VTVT) Stock Rating Upgraded by Zacks Investment Research americanbankingnews.com - May 20 at 4:02 AM
	Zacks Investment Research Upgrades vTv Therapeutics (NASDAQ:VTVT) to Buy americanbankingnews.com - May 16 at 3:02 AM
	vTv Therapeutics GAAP EPS of -$0.10, revenue of $2M seekingalpha.com - May 14 at 6:43 PM
	vTv Therapeutics (NASDAQ:VTVT) Coverage Initiated by Analysts at StockNews.com americanbankingnews.com - May 13 at 1:24 AM
	vTv Therapeutics Announces 2022 First Quarter Financial Results and Provides Corporate Update finance.yahoo.com - May 12 at 11:33 AM
	vTv Therapeutics (NASDAQ:VTVT) Rating Lowered to Hold at Zacks Investment Research americanbankingnews.com - May 12 at 3:20 AM
	vTv Therapeutics (NASDAQ:VTVT) Share Price Crosses Below 50 Day Moving Average of $0.69 americanbankingnews.com - May 5 at 4:52 AM
	Brokerages Anticipate vTv Therapeutics Inc. (NASDAQ:VTVT) Will Announce Earnings of -$0.08 Per Share americanbankingnews.com - May 5 at 2:14 AM
	vTv Therapeutics reports $17.6M loss in 2021, names new acting CEO bizjournals.com - April 1 at 9:04 AM
	vTv Therapeutics (NASDAQ:VTVT) investors are sitting on a loss of 89% if they invested five years ago finance.yahoo.com - March 31 at 11:03 PM
	vTv Therapeutics's Return On Capital Employed Overview benzinga.com - March 31 at 6:02 PM

	vTv Therapeutics Announces 2021 fourth Quarter and Full Year Financial Results and Provides Corporate Update finance.yahoo.com - March 29 at 10:41 PM
	The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan markets.businessinsider.com - March 4 at 2:46 PM
	VTv Therapeutics Says On Feb. 27 Deepra Prasad Notified Board Of Decision To Resign As CEO benzinga.com - March 4 at 3:02 AM
	vTv Therapeutics Announces CEO Transition finance.yahoo.com - March 3 at 10:00 PM
	Cantor Fitzgerald Initiates Coverage On vTv Therapeutics with Overweight Rating, Announces Price Target of $5 benzinga.com - February 18 at 9:43 AM
	vTv Therapeutics Shares Updated Corporate Presentation finance.yahoo.com - January 13 at 10:45 AM
	vTv Therapeutics Inc - Class A Shares Approach 52-Week Low - Market Mover nasdaq.com - December 21 at 7:54 AM
	Triad pharmaceutical company lays off 65% of its workforce two months after leadership change bizjournals.com - December 7 at 6:08 PM
	VTv Therapeutics slashes 65% of workforce, focuses on its diabetes drug finance.yahoo.com - December 7 at 2:26 AM
	vTv Therapeutics Announces Restructuring to Prioritize its Lead Program and Focus Operations finance.yahoo.com - December 6 at 9:26 PM
	Here's Why vTv Therapeutics (VTVT) is Poised for a Turnaround After Losing 15.2% in 4 Weeks finance.yahoo.com - December 3 at 1:35 PM
	Triad pharmaceutical company ranks high in Deloitte’s 2021 Technology Fast 500 list finance.yahoo.com - November 22 at 7:35 AM
	VTv Therapeutics (VTVT) Reports Q3 Loss, Tops Revenue Estimates finance.yahoo.com - November 9 at 2:40 PM
	vTv Therapeutics Announces 2021 Third Quarter Financial Results and Provides Corporate Update finance.yahoo.com - November 9 at 9:39 AM
	Earnings Preview: vTv Therapeutics (VTVT) Q3 Earnings Expected to Decline finance.yahoo.com - October 28 at 8:08 PM
	Here's Why We're Watching vTv Therapeutics' (NASDAQ:VTVT) Cash Burn Situation finance.yahoo.com - October 28 at 3:08 PM
	VTv Names Deepa Prasad New CEO nasdaq.com - October 20 at 10:07 AM
	VTv: Study Result Shows TTP399 Lowers Blood Glucose Without Increasing Risk Of Diabetic Ketoacidosis nasdaq.com - October 12 at 12:11 PM
	vTv Therapeutics Announces Positive Results from Mechanistic Study Indicating No Increased Risk of Ketoacidosis with TTP399 during Acute Insulin Withdrawal in Patients with Type 1 Diabetes finance.yahoo.com - October 12 at 12:11 PM
	UPDATE: vTv Therapeutics Says 'HPP737 exhibited favorable safety and tolerability profile, with no dose limiting gastrointestinal side effects' benzinga.com - September 23 at 7:47 PM
	vTv Therapeutics Announces Results of Multiple Ascending Dose Study and Development Plan for HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis finance.yahoo.com - September 23 at 7:47 PM
	Is vTv Therapeutics (NASDAQ:VTVT) In A Good Position To Invest In Growth? nasdaq.com - September 14 at 4:08 PM

	Multiple insiders bought vTv Therapeutics Inc. (NASDAQ:VTVT) stock earlier this year, a positive sign for shareholders finance.yahoo.com - September 13 at 5:56 PM
	Down 16.1% in 4 Weeks, Here's Why vTv Therapeutics (VTVT) Looks Ripe for a Turnaround finance.yahoo.com - August 17 at 12:20 PM
	VTv Therapeutics (VTVT) Reports Q2 Loss, Lags Revenue Estimates finance.yahoo.com - August 4 at 11:20 PM
	vTv Therapeutics Announces 2021 Second Quarter Financial Results and Provides Corporate Update finance.yahoo.com - August 4 at 6:20 PM
	A Look At vTv Therapeutics' (NASDAQ:VTVT) Share Price Returns nasdaq.com - July 28 at 11:23 PM
	vTv Therapeutics (NASDAQ:VTVT) Share Prices Have Dropped 66% In The Last Five Years finance.yahoo.com - July 27 at 2:40 PM
	vTv Therapeutics to Participate at the 6th World Psoriasis & Psoriatic Arthritis Conference with Poster Presentation on HPP737 finance.yahoo.com - June 29 at 7:52 AM
	vTv Therapeutics Shares Jump On Out-Licensing Agreement For Azeliragon In Cancer Settings finance.yahoo.com - June 22 at 5:59 PM
	Why Moderna, Bio-Path Holdings And vTv Therapeutics Are Moving Today msn.com - June 22 at 12:58 PM
	vTv Therapeutics and Cantex Pharmaceuticals Announce Strategic Licensing Agreement for Development and Commercialization of Azeliragon for Treatment of Cancer finance.yahoo.com - June 22 at 7:58 AM
	vTv Therapeutics Inc. (NASDAQ:VTVT) Insiders Increased Their Holdings nasdaq.com - May 25 at 6:33 PM
	What Kind Of Shareholders Own vTv Therapeutics Inc. (NASDAQ:VTVT)? finance.yahoo.com - May 25 at 1:33 PM
	VTv Therapeutics (VTVT) Reports Q1 Loss, Tops Revenue Estimates finance.yahoo.com - May 5 at 9:52 PM
	vTv Therapeutics Announces 2021 First Quarter Financial Results and Provides Corporate Update finance.yahoo.com - May 5 at 4:48 PM
	vTv Therapeutics Stock Is Believed To Be Significantly Overvalued ca.finance.yahoo.com - April 15 at 11:00 PM
	vTv Therapeutics (VTVT) Gets Breakthrough Tag for Diabetes Drug finance.yahoo.com - April 14 at 1:09 PM

Get vTv Therapeutics News Delivered to You Automatically

This page was last updated on 5/23/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources